白银结核停药后肺部疼痛(河池年人体检中心哪家好) (今日更新中)

The California NAACP is urging "The Star-Spangled Banner" be removed as the national anthem, according to the Sacramento Bee. The NFL has been embroiled in a national controversy regarding players kneeling for the playing of "The Star-Spangled Banner" before games. President Donald Trump has weighed in multiple times condemning players as being disrespectful for kneeling for the anthem.  413

The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines despite efforts by the White House to block them, clearing the way for requirements that are widely expected to prevent the introduction of a vaccine before Election Day.In the new guidelines posted on its website, the FDA said vaccine makers should follow trial participants for at least two months to rule out any major side effects before seeking emergency approval. That standard had been a sticking point between the FDA and White House officials, who said it could unreasonably delay the availability of COVID-19 vaccines.President Donald Trump has repeatedly insisted a vaccine could be authorized before Nov. 3, even though top government scientists working on the effort have said that timeline is very unlikely. On Monday Trump said vaccines are coming “momentarily,” in a video recorded after he returned to the White House.Former FDA officials have warned that public perception that a vaccine was being rushed out for political reasons could derail efforts to vaccinate millions of Americans.A senior administration official confirmed Monday that the White House had blocked FDA’s plans to formally publish the safety guidelines based on the two-month data requirement, arguing there was “no clinical or medical reason” for it.But on Tuesday, the FDA posted the guidance on its website, making clear that regulators plan to impose the safety standards for any vaccine seeking an expedited path to market.FDA Commissioner Stephen Hahn said in a statement that he hoped the guidelines would help “the public understand our science-based decision-making process that assures vaccine quality, safety and efficacy.”The requirements are aimed at companies seeking rapid approval through the FDA’s emergency authorization pathway. That accelerated process, reserved for health emergencies, allows medical products onto the market based on a lower bar than traditional FDA approval. But FDA has made clear only vaccines that are shown to be safe and effective will be authorized for coronavirus.Former FDA acting commissioner Dr. Stephen Ostroff said the requirements seem reasonable given the agency is in largely “uncharted territory” in terms of considering emergency use of a vaccine. The agency has only previously cleared one vaccine through the method — a decades-old shot that was authorized to prevent anthrax poisoning in 2005.“There really is no margin for error here,” Ostroff said. “Even when you’re talking about limited use of a vaccine there has to be some level of assurance that there isn’t a risk here that would far outweigh the benefit.”Dr. Peter Marks, the head of FDA’s vaccine division, said Tuesday that the two-month follow-up requirement was chosen to be “something reasonably aggressive, but not too conservative — right in the middle.” He spoke at a symposium organized by Johns Hopkins University.Initial doses of vaccines for emergency use would likely be reserved for medical workers and people with health conditions that make them particularly vulnerable to coronavirus. Full FDA approval for the general population will require significantly more data and is not expected until mid-2021.The White House attempt to block the guidance followed a string of instances in which the Trump administration has undercut its own medical experts working to combat the pandemic. FDA’s Hahn has been attempting to shore up public confidence in the vaccine review process for weeks, vowing that career scientists, not politicians, will decide if the shots are safe and effective.Pfizer CEO Albert Bourla has stoked excitement by saying that he expects data on whether the company’s candidate works to be ready in late October. But a number of variables would still have to align for the company to submit, and the FDA to review and greenlight, a vaccine application before Nov. 3. Pfizer’s competitors Moderna, AstraZeneca and Johnson & Johnson are working on longer research timelines.Vaccine development typically takes years, but the U.S. government has invested billions in efforts to accelerate the process and help multiple drugmakers prepare multiple candidates. All the doses will be purchased by the federal government for use vaccinating the U.S. population.Beyond exposing the rift between the White House and FDA, the delay in releasing the guidelines may have had limited practical effect.FDA scientists have been discussing the guidelines publicly for weeks and have made clear that the recommendations have already been shared with each of the vaccine developers.Former FDA Commissioner Scott Gottlieb said Tuesday that drugmakers depend on the FDA’s science-based endorsement to vouch for the safety and effectiveness of their products.“I can’t imagine a circumstance where a sponsor would challenge or seek to undermine the FDA’s role here,” Gottlieb said at the COVID-19 symposium. “This is precisely the moment when we need an objective, neutral arbiter.”Last week, Gottlieb and six other former FDA commissioners blasted the Trump administration for “undermining the credibility” of the agency in a op-ed calling for the release of the then-stalled vaccine guidelines.“Scientists should make decisions based on data, unfettered by political pressure or the intrusions of ideology or vested interests,” the officials wrote.___AP Medical Writer Lauran Neergaard contributed to this report.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 5644

The Columbus Zoo in Ohio said visitors helped find a red panda that zookeepers discovered was missing on Wednesday.According to the zoo, visitors notified the zoo that they had spotted Kora, the red panda, around 4:43 p.m. on Thursday near the panda's habitat. The zoo said that after trying to coax the red panda down from a tree, the zoo used a tranquilizer."Amid clapping and happy tears from Zoo team members, the sleeping Kora was placed in her crate and taken to the Zoo’s Animal Health Center for evaluation where she was provided care and given a clean bill of health," the zoo said. "Kora has since been returned to her habitat in Asia Quest, where she will have the opportunity to reunite with her cubs when she wakes. Her care team will continue their overnight watch to ensure they continue to do well, and red panda father, General Tso, will have the opportunity to join them in the morning."The zoo said that the panda didn't pose a threat to the public, but was “eager” to find her.The zoo said that it had moved all of its Asia Quest animals to indoor habitats as officials continue to scour the zoo. The panda had not been seen since Tuesday evening.The red panda is roughly the size of a racoon, and is not a threatening animal. She has two nursing cubs, and the zoo said it had to feed her cubs by using a specialized formula while she was missing.The zoo is one of the busiest in the United States, attracting nearly 2.5 million visitors a year. 1474

The federal government has placed thousands of unaccompanied immigrant children in the homes of sponsors, but last year it couldn't account for nearly 1,500 of them.Steven Wagner, a top official with the Department of Health and Human Services, disclosed the number to a Senate subcommittee last month while discussing the state of the Office of Refugee Resettlement (ORR) that oversees the care of unaccompanied immigrant children.Wagner is the acting assistant secretary for the Administration for Children and Families, which is part of the Department of Health and Human Services. ORR is a program of the Administration for Children and Families.CNN reported earlier this month that, in his testimony, Wagner said during the last three months of 2017, the ORR lost track of nearly 1,500 immigrant children it had placed in the homes of sponsors.Wagner's statement has attracted more attention amid reports that immigrant children are being separated from their parents at the US border. 998

The death toll from the 6.9-magnitude earthquake that hit the Indonesian island of Lombok more than a week ago has surged to 436, authorities said Monday.The number is expected to rise further as search and rescue efforts continue in the rubble strewn across the island by the quake and another one that struck on August 9.Indonesia's National Disaster Management Agency (BNPB) has been working with the country's military and police to supply aid and food to the 350,000 people displaced by the quakes.As of Monday, 21 tonnes of aid had been delivered on a cargo plane, according to BNPB spokesperson Sutopo Purwo Nugroho. 631

来源：资阳报